3rd Immune Effector Cell Therapies in Multiple Myeloma Workshop

May 7 - 8, 2022 - Boston, MA

Building upon the success of prior workshops, the International Myeloma Society is happy to host the 3rd Immune Effector Cell Therapies in Multiple Myeloma Workshop to discuss various immune-based therapies in myeloma including CART cell clinical data and promising preclinical leads, review the latest correlative analyses exploring predictors of response and resistance mechanisms, evaluate uniform practices in managing patients with CRS and other complications, and discuss next-generation cell therapy strategies, including “off-the-shelf” allogeneic and NK-cell based approaches. This year we are also including a session on cell-engaging bispecific antibody-based approaches. 

Preliminary Agenda

Thank you to our sponsors:

Registration rates

Registration Category In Person Rate Virtual Rate
Member $425.00 $0.00
Non-Member $525.00 $100.00
Non-Members in Training $100.00 $50.00
Pharma Industry $600.00 $150.00


Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events